Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gatifloxacin 400 mg as a single shot or 200 mg once daily for 3 days is as effective as ciprofloxacin 250 mg twice daily for the treatment of patients with uncomplicated urinary tract infections.
Naber KG, Allin DM, Clarysse L, Haworth DA, James IG, Raini C, Schneider H, Wall A, Weitz P, Hopkins G, Ankel-Fuchs D. Naber KG, et al. Among authors: hopkins g. Int J Antimicrob Agents. 2004 Jun;23(6):596-605. doi: 10.1016/j.ijantimicag.2003.12.017. Int J Antimicrob Agents. 2004. PMID: 15194131 Clinical Trial.
Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: the COMPASS Equivalence Trial. Comparison Trial of Saruplase and Streptokinase (COMASS) Investigators.
Tebbe U, Michels R, Adgey J, Boland J, Caspi A, Charbonnier B, Windeler J, Barth H, Groves R, Hopkins GR, Fennell W, Betriu A, Ruda M, Mlczoch J. Tebbe U, et al. Among authors: hopkins gr. J Am Coll Cardiol. 1998 Mar 1;31(3):487-93. doi: 10.1016/s0735-1097(97)00553-6. J Am Coll Cardiol. 1998. PMID: 9502624 Free article. Clinical Trial.
Thrombolysis with recombinant unglycosylated single-chain urokinase-type plasminogen activator (saruplase) in acute myocardial infarction: influence of heparin on early patency rate (LIMITS study). Liquemin in Myocardial Infarction During Thrombolysis With Saruplase.
Tebbe U, Windeler J, Boesl I, Hoffmann H, Wojcik J, Ashmawy M, Rüdiger Schwarz E, von Loewis P, Rosemeyer P, Hopkins G, et al. Tebbe U, et al. Among authors: hopkins g. J Am Coll Cardiol. 1995 Aug;26(2):365-73. doi: 10.1016/0735-1097(95)80008-5. J Am Coll Cardiol. 1995. PMID: 7608436 Free article. Clinical Trial.
Comparison of saruplase and alteplase in acute myocardial infarction. SESAM Study Group. The Study in Europe with Saruplase and Alteplase in Myocardial Infarction.
Bär FW, Meyer J, Vermeer F, Michels R, Charbonnier B, Haerten K, Spiecker M, Macaya C, Hanssen M, Heras M, Boland JP, Morice MC, Dunn FG, Uebis R, Hamm C, Ayzenberg O, Strupp G, Withagen AJ, Klein W, Windeler J, Hopkins G, Barth H, von Fisenne MJ. Bär FW, et al. Among authors: hopkins g. Am J Cardiol. 1997 Mar 15;79(6):727-32. doi: 10.1016/s0002-9149(97)89274-0. Am J Cardiol. 1997. PMID: 9070549 Clinical Trial.
Thrombolysis with saruplase versus streptokinase in acute myocardial infarction: five-year results of the PRIMI trial.
Spiecker M, Windeler J, Vermeer F, Michels R, Seabra-Gomes R, vom Dahl J, Kerber S, Verheugt FW, Westerhof PW, Bär FW, Nixdorff U, Barth H, Hopkins GR, von Fisenne MJ, Meyer J. Spiecker M, et al. Among authors: hopkins gr. Am Heart J. 1999 Sep;138(3 Pt 1):518-24. doi: 10.1016/s0002-8703(99)70155-9. Am Heart J. 1999. PMID: 10467203 Clinical Trial.
Saruplase in Myocardial Infarction.
Bär FW, Vermeer F, Michels R, Boland J, Meyer J, Hopkins G, Barth H, Grünzler WA. Bär FW, et al. Among authors: hopkins g. J Thromb Thrombolysis. 1995;2(3):195-204. doi: 10.1007/BF01062710. J Thromb Thrombolysis. 1995. PMID: 10608024
305 results